The Do-Or-Die Struggle For Growth
The Do-Or-Die Struggle For Growth
The Do-Or-Die Struggle For Growth
Feature Article
The largest corporations rarely sustain strong growth unless they compete in the right places at the right times.
2005 Number 3
Growth is once again top of mind for business executives. As they turn their attention from improving the
operational performance of their companies to making those companies grow again, many of them will follow the
standard message: consistently strong, value-creating revenue growth lies within reach of major corporations that
pursue best practice in strategy, marketing, operations, and organization.
Or does it? Execution and fundamentals are certainly vital, but growth, particularly for the largest companies,
requires more than best practice. At the median annual revenue level of today's Fortune 100—about $30 billion—
a corporation would in effect have to create a $2 billion company each year to sustain 6 percent top-line growth.
Can investors and capital markets reasonably expect that kind of performance? How do some companies achieve
it?
To explore the particular challenges of revenue growth in big corporations, we studied the performance of about
100 of the largest ones in the United States, in 17 sectors, over the two most recent business cycles. Almost a
third of the companies managed to increase their revenues at a rate faster than the growth of GDP over the
second cycle, from 1994 to 2003, while at the same time delivering shareholder returns above those of the S&P
500 index. The relatively large number of high performers here might indicate that the odds for companies
aspiring to grow are decent, if not for a sobering fact: 90 percent of these companies were concentrated in just
four sectors—financial services, health care, high tech, and retailing.
It isn't surprising that they are overrepresented. These sectors as a whole, or markets and segments within them,
offer favorable growth environments supported by established trends: aging populations, rapid product or format
innovation, deregulation, and consolidation. What's striking for large growth-minded corporations is just how
crucial it is to have this kind of favorable wind at their backs when they try to achieve strong growth.
Looking across the two economic cycles also revealed the critical role of top-line growth. Large companies that
trailed GDP for an entire business cycle were five times more likely to be acquired or otherwise go out of business
than were faster growers. Eventually, companies that don't increase their revenues run out of ways to drive
earnings and shareholder returns. Even if a company finds a way to create shareholder value, slow-growing
companies remain attractive acquisition targets.
These findings have broad implications for management. The first is that large companies need to pay at least as
much attention to top-line growth as to increasing the bottom line. While cost improvements can drive earnings
and shareholder value in the near term, companies that raise their total returns to shareholders (TRS) without
achieving top-line growth have the worst long-term odds of survival. Many companies that struggle to grow do
indeed face a "grow-or-go" situation.
Second, where to compete is just as important as how. The choices a large company makes today about its
portfolio mix and where to place its bets will shape its growth trajectory over the next five to ten years. Unless the
company enjoys the advantages of fast-growing pools of revenues and profits or has ample opportunity to
consolidate, growth that just keeps pace with GDP will be difficult to sustain, even if execution is great.
Our research focused on 102 US public companies: the top 75 in 1994 revenues and the top 75 in 1994 market
capitalization. We tracked these companies over the 1994–2003 business cycle and segmented their growth
performance by revenues (including acquisitions and divestitures) and TRS, which encompasses both share prices
and dividends. The median compound annual growth rate (CAGR) for revenues was around 5 percent,
corresponding to nominal GDP growth over the period. At 11 percent, the median annual growth rate of TRS was
roughly equal to that of TRS for the S&P 500 index.
enlarge exhibit
Thirty-two companies occupy our growth giants category, and most of them—20 percent of the overall sample—
achieved double-digit revenue growth over the period while outperforming the S&P 500 on TRS (Exhibit 1). That
accomplishment struck us as particularly impressive, even if more than half of these companies used acquisitions
extensively1 to drive top-line growth.
Although we found a positive relationship between the growth of revenues and of TRS over the ten-year period,
exceptions abounded. Companies that increased their revenues at a rate faster than the growth of GDP were 60
percent more likely to outperform the S&P 500 index. But nearly 20 percent outperformed it despite sluggish top-
line growth. In fact, the median TRS performer increased its revenue by only 3 percent but, like the growth giants,
boasted average TRS growth of 16 percent.
As might be expected, the TRS performers compete mostly in slower-growth industries, such as consumer goods,
engineering and construction, and utilities. The keys to their ability to create value were good execution, cost
controls, and savvy portfolio management—all of which generated strong earnings growth. Many of these
companies sold or exited lower-margin businesses and bought or entered higher-margin ones. Half of the TRS
performers increased their earnings at a rate at least twice that of their revenues, and 37 percent pursued major
divestiture programs.2
Next we asked what might happen over the longer term. How would the TRS performers and the growth giants
cope in a subsequent business cycle? Could they maintain their momentum for an additional five or ten years?
And what of the challenged and unrewarded companies—could they turn their TRS around, or did another
outcome await them?
To find out, we chose a slightly different sample and a longer time horizon. With the same method we used for our
first sample, we identified the 100 largest US public companies in 1984 and then followed their performance over
the business cycles of 1984–93 and 1994–2003. When we segmented the performance of these companies during
the earlier business cycle, only 20 percent made the grade as growth giants (Exhibit 2, part 1).
enlarge exhibit
We then tracked the companies from each quadrant into the 1994–2003 cycle, examining patterns of survival and
TRS performance. The correlation between the future survival of a company and its past revenue growth—but not
its TRS—was striking. A company whose revenue increased more slowly than GDP did was five times more likely
to succumb, usually through acquisition, than a company that expanded more rapidly (Exhibit 2, part 2). Past TRS
performance, by contrast, was a surprisingly poor indicator of corporate survival.
Past revenue growth was also a superior predictor of future TRS performance. Almost half (45 percent) of the
growth giants sustained their outperformance in both top-line growth and value creation through the 1994–2003
cycle, and nearly two-thirds continued creating value at a high rate. Even the unrewarded top-line growers from
the previous decade had a better than even chance of surviving and outperforming during the 1994–2003 cycle
(Exhibit 2, part 3). It was the challenged companies and, above all, the TRS performers that had the worst odds.
The reason is straightforward: most TRS performers from the 1984–93 cycle competed in slower-growth
industries, such as utilities and telecommunications, which consolidated during the subsequent one. Most of those
that weren't acquired continued to struggle with revenue and earnings growth. Unless these companies embarked
on a successful acquisitions program or shifted their business mix, they couldn't capture enough gains from
reducing costs or restructuring in their existing businesses to compensate for the lack of top-line growth.
Companies that don't increase the top line eventually hit a TRS wall and often become targets for acquisition.
Even the largest companies may therefore find themselves grappling with fundamental grow-or-go decisions.
Where to compete
How does a large company achieve and maintain strong growth? Our analysis of the 32 growth giants in the
1994–2003 sample reveals a sobering reality: good execution is required, but being in the right business at the
right time is almost always a prerequisite as well.
Four sectors—financial services, health care, high tech, and retailing—collectively accounted for half of all large
companies in our sample but for nearly 90 percent of all growth giants in the 1994–2003 cycle (Exhibit 3). The
overall economy grew at a rate of 5 percent during those years. Meanwhile, financial services, supported by
deregulation, increased borrowing, and the trend toward broader participation in equity markets, grew by 7
percent. So did high tech, propelled by the innovation and information revolution of the 1990s; high-tech services
grew even more robustly, at 9 percent.
enlarge exhibit
Health care expenditures grew by 7 percent as a result of innovation and an aging population. Most of the health
care growth giants, such as Johnson & Johnson, Eli Lilly, and Pfizer, were concentrated in pharmaceuticals, which
expanded even more quickly—by a 12.5 percent CAGR from 1994 to 2003. A similar story unfolded in retailing,
which expanded by only 4.5 percent as a whole but much faster in segments where growth giants competed. Wal-
Mart Stores' format innovations in the late 1980s, for instance, boosted growth in the overall discount-store
segment, to the benefit of followers like Target. In the home-improvement segment, Lowe's, another growth
giant, revamped its store format and capitalized on the do-it-yourself craze that The Home Depot created in the
1980s.
Good execution is needed for strong growth, but so is competing in the right business at the right time
Since most growth giants had the benefit of a favorable growth environment, more than 70 percent of them (23 in
all) succeeded in generating impressive financial results by exploiting opportunities in their existing businesses.
Most of these companies focused on incremental product innovations or consolidation or on the geographic
expansion of a business model or a series of products within the United States. For the 3 growth giants lacking a
tailwind, consolidation in the core business was the preferred strategy. 3
Breakthrough innovations—new products, retail formats, supply chain models, and so forth that change the
competitive game or produce a distinct competitive advantage—were unusual for large companies. We found only
four growth giants that developed such innovations during the 1994–2003 cycle and used them as the primary
driver of growth. All of them were new products from R&D-intensive industries that experienced a tailwind:
technology and health care. None of the growth giants owed their achievements to reinventing the business
model. While radical innovations of this kind have propelled companies (such as Dell) from relative obscurity to
the Fortune 100, they are rarely pursued or executed successfully after companies become large.
Not all growth giants stuck to their knitting; the other 30 percent (nine in all) extended the scope of their
portfolios by building or acquiring new businesses or expanding into global markets. 4 Except for the diversified
conglomerate Berkshire Hathaway, all of the growth giants entered adjacent customer or product markets or
focused on internationalizing a successful business model or series of products. Seven of the nine companies used
acquisitions to enter new markets.
But success in building businesses was about more than acquisitions or customer and product strategies. The
companies that excelled at it had either truly distinctive capabilities or operational assets that created a real
competitive advantage in the new arena. Johnson & Johnson and Medtronic, for example, use acquisitions to enter
new product spaces but drive organic growth by leveraging excellent product development and commercialization
capabilities and superior relationships with doctors, hospitals, and other customers. Of the nine business builders,
eight took advantage of industry momentum by building or acquiring new operations in health care, financial
services, or technology.
Only one growth giant built a big new business without the backdrop of a rapidly growing market: Wal-Mart, which
used its network of stores, its brand, its supply chain expertise, and a format innovation to enter the relatively
slow-growing US market for perishable grocery products. The other business builders may or may not have been
looking for the next favorable business environment. Creating a new business, however, not only gave them
opportunities to behave and grow like an attacker but also provided moderate diversification if the prevailing
favorable winds were to shift in the core business. 5
How did Wal-Mart drive format and other innovations in the retail sector? See "Retail: The Wal-Mart effect."
The experience of the large companies that we followed across the 1984–93 and 1994–2003 business cycles
shows how difficult it is to grow without a tailwind. Although almost half of these companies maintained their
status as growth giants through the two cycles, all except Wal-Mart had or built new businesses in health care or
financial services—sectors that were hot in both cycles. Similarly, most companies in the challenged category
from 1984 to 1993 lumbered along in industries that were then growing slowly: automotive, defense, oil, and
utilities. Twenty percent of the challenged companies (7 of 37) managed to become growth giants during the next
cycle, but a favorable environment was important: five of the seven growth turnarounds took place in industries
whose conditions improved dramatically. Only 2 companies moved from our challenged category to become
growth giants without substantial growth in demand. Both were grocery chains that relied heavily on
consolidation, investing at least 80 percent of their 2003 market cap in acquisitions over the period.
In 1994, for example, ITT Industries was a diversified conglomerate with holdings ranging from hotels to defense
electronics. It then decided to concentrate on two segments—defense electronics and fluid technologies (pumps,
mixers, and valves)—that seemed likely to grow and were well aligned with ITT's capabilities. The rest of the
portfolio was spun off, and these divestitures not only created substantial value for shareholders but also gave the
remaining parts of ITT a strong operational focus in segments with favorable growth conditions. In 2003, the
company's revenue had reached only 70 percent of its 1994 level, so ITT wasn't a growth giant by our criteria. It
did, however, increase its annual TRS by 18 percent during this portfolio transition, and the remaining businesses
are growing rapidly, by an average of 18 percent over the past three years.
IBM's turnaround strategy also focused on the portfolio, although the company did less pruning and put greater
emphasis on building new businesses. Management believed that IBM's brand, customer relationships, and
engineering skills could propel growth in the emerging IT services market. From 1994 to 2003, the company's
largely organic growth in services ranged from 15 to 20 percent, and the proportion of its corporate revenue from
services, starting out at 25 percent, rose to almost 50 percent. 6 These strong growth prospects have been a major
driver of the company's TRS—almost 22 percent a year during the sample period.
Viewed over the course of ten years, the top-line growth performance of ITT, IBM, and other companies that
transformed their portfolios was characterized by divestitures or strategic decisions to exit businesses with
relatively low growth potential. These transformations created considerable shareholder value and gave such
companies a better position to increase their revenues and TRS in the next cycle.
Grow or go?
When a large company faces a headwind in its existing businesses, consolidation and efforts to transform the
portfolio are its most plausible ways to grow. Even so, these are not without risk.
Consolidation strategies have a better chance for success when a company can show that it has "earned the right
to buy." Do its operating margins and returns on invested capital (ROIC) compare favorably with those of its
industry peers? Has it created value through mergers and acquisitions in the past? The answers to these
questions—as well as the industry's readiness for consolidation—have a direct bearing on whether buying makes
more sense than selling.
M&A skills and sound operations are part of the picture for any company that considers transforming its portfolio.
But it is even more important to place the right bets on where to compete. A company must not only figure out
which markets are likely to be attractive but also have a realistic view of its own capabilities. Are any of them
powerful enough to confer a competitive advantage in a new geography, product, or customer segment—or even
a different sector? The importance of having a real competitive advantage holds whether an entry strategy calls
for organic growth or acquisitions.
The bar for distinctive capabilities is high. A company may believe that it has them in logistics or the supply chain,
for example. But are they so strong that customers of other companies will switch? Will these capabilities support
a price premium or allow the company to maintain operating margins that competitors can't match? If the answer
to all of these questions is no, the capabilities don't provide a true competitive advantage; they are merely things
the company does well.
For companies struggling to increase their revenues, a high bar to investments in new capabilities, markets, and
growth seems particularly well justified. One-third of the 37 challenged companies from the 1980s chose to sell
before 2003. As a group, the sellers performed well, realizing median compound annual TRS growth of 19 percent
from 1994 to the time of sale, as compared with only 11 percent for the median survivor in the challenged
category. In other words, unless your company has a reasonable chance of turning itself around, don't dismiss the
"sell" option too quickly.
As a company becomes larger, the question of where it should compete becomes more critical. Choosing the right
battlegrounds means matching its distinctive capabilities to the businesses, customers, products, and
geographies where profitable growth is most likely to occur and acting on those insights before it's too late. A
company that struggles with growth may have few distinctive capabilities. Building or acquiring new ones that can
Sven Smit is a director in McKinsey's Amsterdam office; Caroline Thompson is a consultant and Patrick
Viguerie is a director in the Atlanta office.
Notes
1
In our terminology, an extensive acquirer has made acquisitions totaling at least 20 percent of its market
capitalization at the end of a given period.
2
A company that made extensive divestitures sold assets worth at least 20 percent of its 2003 market
capitalization.
3
Dow Chemical, Kroger, and Safeway. All were consolidators.
4
We considered new businesses or geographies to be significant if they accounted for less than 5 percent of a
company's revenue at the start of the period and for at least 15 percent by its end.
5
Neil W. C. Harper and S. Patrick Viguerie, "Are you too focused?" The McKinsey Quarterly, 2002 special edition:
Risk and resilience, pp. 28–37.
6
Excluding maintenance and software.